cereneo
cereneo is a Swiss neurorehabilitation clinic group offering high-tech inpatient, outpatient, home, and online therapy for stroke, Parkinson's, TBI, and MS patients from its Weggis-area clinics and Netherlands-based home services unit.
- Company typePrivate
- Founded2012
- HeadquartersWeggis, Switzerland
- Headcount101–250
- GTM typeB2C
- OfferingServices
What cereneo does
cereneo is a Swiss neurorehabilitation clinic group founded in 2012 and headquartered in Weggis, Switzerland, operating across multiple legal entities including cereneo Schweiz AG for clinical operations, cereneo International AG for international patient services, and cereneo Home B.V. in the Netherlands for home-based and online therapy delivery. With 101-250 employees and ISO 9001 certification, the company delivers specialized inpatient, outpatient, home, and online rehabilitation to patients recovering from neurological conditions such as stroke, Parkinson's disease, traumatic brain injury, and multiple sclerosis. Its clinical program is anchored on a capital-intensive technology stack including robotic gait and balance systems (CAREN, Lokomat, ZeroG, exoskeletons), VR-based training, non-invasive brain stimulation (tVNS via the SmartVNS partnership with Skaaltec, tDCS, TMS), wearable motion sensors, and a dedicated sleep laboratory. Research collaborations with Johns Hopkins University, KU Leuven, ETH Zurich, and the University of Zurich, alongside an in-house research institute (LLUI) and the cereneo Foundation, support evidence generation and clinical validation.
Revenue is generated through quote-based pricing across inpatient stays (long-duration, recurring), home-based rehabilitation subscriptions, online/telerehabilitation sessions, and specialized professional services, with an international patient segment sitting alongside Swiss domestic demand. Go-to-market relies on clinical reputation, physician referrals, and direct patient acquisition for international inbound flow. A related brand entity, cereneo Prevention, indicates planned extension into pre-acute or wellness-oriented services. Leadership includes Prof. Dr. med. Andreas Luft as President of the Board, Dennis Marschalleck as Managing Director of cereneo Schweiz AG, Frenske van den Dries as Managing Director of cereneo Home, Dr. Meret Branscheidt as Medical Director Hertenstein, and Shari Langemak as Director Innovation & Business Development.
cereneo firmographics
Firmographics- Name
- cereneo
- Legal name
- cereneo Schweiz AG
- Website
- https://cereneo.ch
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- cereneo is a Swiss neurorehabilitation clinic group offering high-tech inpatient, outpatient, home, and online therapy for stroke, Parkinson's, TBI, and MS patients from its Weggis-area clinics and Netherlands-based home services unit.
- Ownership category
- akta.pro rank
cereneo industry classification
Industry- Product category
- Neurorehabilitation Services
- NAICS
- Services for the Elderly and Persons with Disabilities (624120)
- SIC
- Services-Skilled Nursing Care Facilities (8051), Services-Home Health Care Services (8082), Services-Nursing & Personal Care Facilities (8050)
- akta.pro primary industry
- Neurorehabilitation Centers (HLAFAFAH)
- akta.pro secondary industries
- Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s) (HSABADAE), Stroke & Vascular Neurology (HLAKAIAG)
Keywords
Where cereneo is headquartered
LocationHeadquarters
- HQ city
- Weggis
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
cereneo business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Inpatient Neurorehabilitation: Residential rehabilitation programs at clinic facilities in Switzerland including accommodation, meals, and comprehensive therapy services
- Home Rehabilitation Services: Cereneo Home services including therapist home visits and online therapy sessions for patients worldwide
- Online/Telerehabilitation: Virtual therapy sessions and online doctor consultations for remote patients
- Specialized Therapy Services: Individual therapy sessions including physiotherapy, occupational therapy, speech therapy, neuropsychology, and nutritional counseling
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Individualized rehabilitation programs with pricing based on specific treatment needs and duration |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels5 records
cereneo product offering
Product offeringCore offering
cereneo provides personalized neurorehabilitation through inpatient clinics at Hertenstein and Vitznau, home-based rehabilitation programs via cereneo Home, and online therapy platforms. Services target patients recovering from stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury, and other neurological conditions. Treatment combines intensive one-on-one therapy with advanced rehabilitation technologies including robotic gait therapy, virtual reality, and non-invasive brain stimulation.
Product overview
cereneo is a Swiss neurorehabilitation clinic offering a comprehensive, holistic approach to neurorehabilitation through three interconnected service streams: inpatient rehabilitation at its clinics in Hertenstein (Weggis) and Vitznau, home-based therapy through cereneo Home services, and online/telerehabilitation. The organization provides personalized treatment for neurological conditions including stroke, Parkinson's disease, Multiple Sclerosis, and traumatic brain injuries. cereneo integrates advanced medical technologies including robotic gait systems (CAREN, Lokomat, ZeroG, Exoskeleton), brain stimulation technologies (tDCS, TMS, tVNS/SmartVNS), wearable monitoring sensors, and digital therapeutic tools. Treatment modalities include physiotherapy, occupational therapy, speech and language therapy, neuropsychology, and psychological support, delivered by an interdisciplinary team of neurologists, therapists, nurses, engineers, and researchers.
Differentiator
Problem solved
Functional benefit
Products and services
- Inpatient Rehabilitation
Quantifiable outcome
- High-intensity therapy model with 6+ average therapy sessions per patient per day
- +2 more outcomes
Companies that use cereneo
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles2 records
cereneo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature11 records
cereneo partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, flagship, regional and minor.
- University of ZurichcoreAcademic partnership for joint neuroscientific studies to advance neurorehabilitation, establish objective measurement standards, and develop new interventions and technologies.
- Lake Lucerne Institute (LLUI)coreResearch institute partnership including Therapy Science Lab collaboration and DART group (Data Analysis and Rehabilitation Technology) for developing rehabilitation technology solutions.
- cereneo FoundationcoreCharitable foundation supporting neurorehabilitation research initiatives and studies conducted at cereneo clinics.
- Johns Hopkins UniversityflagshipInternational research partnership with one of the world's leading academic medical centers for advancing neurorehabilitation science.
- KU LeuvenflagshipEuropean research university partnership contributing to cereneo's international academic network and research collaborations.
- ETH ZurichcoreTechnology partnership with ETH's RELab for developing rehabilitation technologies including the SmartVNS system through spin-off Skaaltec.
- University Hospital Zurich (USZ)coreSwiss hospital partnership for patient referrals and clinical collaboration in neurological care.
- Spital SchwyzregionalRegional hospital partnership for patient referrals and continuity of care in neurorehabilitation.
- Schulthess KlinikregionalSwiss specialist clinic partnership for orthopedic and neurological patient referrals.
- The Loop ZurichregionalResearch hub partnership in Zurich's innovation ecosystem for technology and research collaboration.
- SkaalteccoreTechnology partnership with ETH RELab spin-off for SmartVNS system - AI-powered, motion-controlled tVNS device for upper extremity rehabilitation in stroke and spinal cord injury patients.
- cereneo PreventionminorRelated brand entity offering prevention services, operating under separate website (cereneo-prevention.com).
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
cereneo competitors and assessment
Company assessmentOthers
- Hocoma (DIH): Swiss manufacturer of robotic rehab devices (Lokomat, Armeo) that cereneo uses; relevant adjacent peer reflecting the same robotics-enabled neurorehab thesis, on the device-vendor side.
Emerging players
- Kaia Health: Digital therapeutic platform for MSK and chronic conditions; comparable as a software-delivered home rehab alternative to cereneo's telerehabilitation and self-training app offerings.
- MindMaze: Swiss-founded neurotechnology company building digital therapeutics and VR/gaming-based rehab for stroke and brain injury — directly comparable technology stack (VR, brain stimulation, neurorehab).
- Sword Health: Digital musculoskeletal and neurological rehabilitation platform providing AI-enabled remote therapy — competes with cereneo's online/home rehabilitation arm with a tech-first, asset-light model.
Direct peers
- MediClin: German operator of inpatient rehabilitation clinics (including neurological rehab), similar multi-site specialty rehab model to cereneo with broader geographic coverage in DACH.
- RehaClinic: Swiss rehabilitation clinic group operating inpatient and outpatient rehab facilities, directly comparable to cereneo's Swiss clinic footprint and multidisciplinary rehab model.
- Burke Rehabilitation Hospital: New York-based specialty neurorehabilitation hospital for stroke, TBI, Parkinson's, and MS, comparable inpatient rehab model and patient mix to cereneo.
- Shirley Ryan AbilityLab: US-based research hospital specializing in physical medicine and neurorehabilitation for stroke, TBI, and spinal cord injury, with strong academic/research output — directly comparable in clinical mission and tech-enabled approach.
Broad incumbents
- VAMED Rehabilitation Clinics: Austrian-headquartered global healthcare provider operating post-acute and rehabilitation facilities, comparable in patient population (neurological, post-acute) but larger and more diversified.
- Helios Kliniken / Fresenius Helios: Large European private hospital group offering inpatient and rehabilitation services including neurology; comparable patient segments but operates across many specialties at much greater scale.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
cereneo social profiles
Digital presencecereneo compliance and trust
Trust signalCompliance2 records
cereneo financial estimates
Financial estimateRevenue estimate
Valuation estimate
cereneo leadership team
Management profileNumber of profiles
Profiles6 records
cereneo subsidiaries and ownership
Company hierarchySubsidiaries2 records
cereneo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
cereneo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about cereneo
What does cereneo do?
cereneo provides personalized neurorehabilitation through inpatient clinics at Hertenstein and Vitznau, home-based rehabilitation programs via cereneo Home, and online therapy platforms. Services target patients recovering from stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury, and other neurological conditions. Treatment combines intensive one-on-one therapy with advanced rehabilitation technologies including robotic gait therapy, virtual reality, and non-invasive brain stimulation.
Is cereneo a public or private company?
cereneo is a private company. It is classified as unknown and is currently operating.
When was cereneo founded?
cereneo was founded in 2012. It employs 101 to 250 people.
Where is cereneo based?
cereneo is headquartered in Weggis, Switzerland, in the Europe region.
How does cereneo make money?
Four revenue lines are on record. Inpatient Neurorehabilitation is the primary driver. The others are home Rehabilitation Services, online/Telerehabilitation and specialized Therapy Services.
Who are cereneo's main competitors?
Hocoma (DIH) is listed as an others. Emerging players are Kaia Health, MindMaze and Sword Health. Direct peers are MediClin, RehaClinic, Burke Rehabilitation Hospital and Shirley Ryan AbilityLab. Broad incumbents are VAMED Rehabilitation Clinics and Helios Kliniken / Fresenius Helios.
Does cereneo have an API?
No public API is recorded for cereneo.
What industry is cereneo in?
cereneo's product category is Neurorehabilitation Services. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s). Its NAICS code is 624120 and its SIC code is 8051.